PTJ
XERS icon

Paul Tudor Jones’s Xeris Biopharma Holdings XERS Stock Holding History

Paul Tudor Jones’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
22,186
-85,228
-79% -$544K ﹤0.01% 3351
2026
Q1 		$623K Buy
107,414
+85,228
+384% +$565K ﹤0.01% 2676
2025
Q4 		$174K Sell
22,186
-15,808
-42% -$124K ﹤0.01% 3327
2025
Q3 		$309K Sell
37,994
-187,192
-83% -$1.24M ﹤0.01% 2957
2025
Q2 		$1.05M Hold
225,186
– – ﹤0.01% 2101
2025
Q1 		$1.24M Sell
225,186
-80,000
-26% -$323K ﹤0.01% 1676
2024
Q4 		$1.03M Sell
305,186
-202,171
-40% -$650K ﹤0.01% 1707
2024
Q3 		$1.45M Sell
507,357
-65,829
-11% -$169K 0.01% 1405
2024
Q2 		$1.29M Hold
573,186
– – 0.01% 1324
2024
Q1 		$1.27M Buy
573,186
+19,775
+4% +$51.2K 0.01% 1224
2023
Q4 		$1.3M Sell
553,411
-88,087
-14% -$163K 0.01% 1324
2023
Q3 		$1.19M Sell
641,498
-216,913
-25% -$497K 0.01% 1211
2023
Q2 		$2.25M Sell
858,411
-101,700
-11% -$259K 0.03% 835
2023
Q1 		$1.56M Hold
960,111
– – 0.02% 920
2022
Q4 		$1.28M Hold
960,111
– – 0.03% 934
2022
Q3 		$1.5M Hold
960,111
– – 0.03% 663
2022
Q2 		$1.48M Sell
960,111
-1,081
-0.1% -$2.28K 0.04% 661
2022
Q1 		$2.46M Buy
961,192
+1,081
+0.1% +$2.64K 0.06% 452
2021
Q4 		$2.81M Buy
+960,111
New +$2.07M 0.05% 482

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Paul Tudor Jones's XERS Position: Q2 2026 in Review

Paul Tudor Jones reduced its Xeris Biopharma Holdings (XERS) stake by 79% in Q2 2026, selling an estimated $544K and leaving 22,186 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

Paul Tudor Jones first reported a position in XERS in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.81M in Q4 2021. 237 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Paul Tudor Jones held 22,186 shares of Xeris Biopharma Holdings worth $176K as of Q2 2026.
  • Paul Tudor Jones sold 85,228 Xeris Biopharma Holdings shares in Q2 2026, an estimated $544K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3351 holding.
  • Paul Tudor Jones first reported a position in Xeris Biopharma Holdings in Q4 2021 and has held it in 19 quarters since.
  • Paul Tudor Jones's Xeris Biopharma Holdings position peaked at $2.81M in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.